Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.

Conditions: Gastric Cancer Interventions: Drug: Tislelizumab; Drug: SOX/XELOX Sponsors: Xiangdong Cheng; Liaoning Tumor Hospital& Institute; Shanxi Province Cancer Hospital; Sichuan Cancer Hospital and Research Institute; The Second Affiliated Hospital of Harbin Medical University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials